Bosentan 62.5Mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Bosentan 62.5Mg Tablets Specification

Life Span
Check expiry on pack

Dosage Form
Tablet

Indication
Treatment of pulmonary arterial hypertension (PAH)

Pacakaging (Quantity Per Box)
Indicated on pack, varies by manufacturer

Origin of Medicine
India

Salt Composition
Bosentan 62.5mg

Brand Name
Bosentas

Packaging Type
Box

Drug Type
Prescription only

Ingredients
Bosentan

Physical Form
Tablet

Function
Endothelin receptor antagonist

Recommended For
Pulmonary arterial hypertension patients

Dosage
As prescribed by physician

Dosage Guidelines
Take orally with or without food, follow medical advice

Suitable For
Adults

Quantity
As per pack specification

Storage Instructions
Store in a cool, dry place away from sunlight

Color
As per manufacturer

Warning
To be used only under medical supervision

Shape
As per manufacturer

Marketed By
Cipla Ltd.

Strength
62.5 mg

Country of Approval
Approved in Canada, EU, UK, USA, Australia

Administration Route
Oral

Prescription Required
Yes

Bosentan 62.5Mg Tablets About

Discover the latest Bosentan 62.5mg Tablets from Cipla Ltd., now with an exciting price cut for optimal value. This remarkable treatment, famed for its efficacy in managing pulmonary arterial hypertension (PAH), offers uncommon relief under expert medical supervision. Enjoy instant checkout for prescription orders, ensuring fast and secure access to your medication. Approved and trusted across Canada, EU, UK, USA, and Australia, Bosentas delivers consistent results. Each oral tablet contains 62.5 mg Bosentan in a convenient box, suitable for adult patients as prescribed by physicians. Prescription required.

Bosentan 62.5Mg Tablets: Unique Benefits and Features

Bosentan 62.5mg Tablets stand out for their remarkable ability to reduce blood pressure in pulmonary arteries, improving exercise capacity and symptoms in adults with PAH. The added advantage lies in their oral administration, allowing convenient dosing as advised by your doctor. Beyond primary usage, these tablets may offer additional cardiovascular support under medical guidance. Each pack ensures accurate composition and storage instructions, emphasizing patient safety and efficacy, making Bosentas a trusted option among endothelin receptor antagonists.

Market Reach, Exports, and Special Price Offers

Bosentan 62.5mg Tablets are renowned in the domestic market across India and the global export market, including the USA, UK, EU, Canada, and Australia. Delivered directly by verified manufacturers, suppliers, and traders, supply rates meet high demand with reliable availability. Take advantage of our lowest price offers and competitive deals, making life-saving therapy more accessible. Each offer ensures original packaging and batch specifications, delivering consistent quality at every point of sale.

FAQ's of Bosentan 62.5Mg Tablets:

Q: How should Bosentan 62.5mg Tablets be taken for the best results?

A: Bosentan 62.5mg Tablets must be taken orally, with or without food, strictly as prescribed by your physician. Consistent adherence to your doctor's dosage guidance will ensure maximum benefit and safety.

Q: What conditions are Bosentan 62.5mg Tablets primarily used to treat?

A: These tablets are mainly indicated for treating pulmonary arterial hypertension (PAH), helping to lower blood pressure in the lungs and improve physical activity capacity in affected adults.

Q: When is a prescription required for Bosentan 62.5mg Tablets?

A: A valid prescription from a qualified medical professional is mandatory before purchasing Bosentan 62.5mg Tablets, as they are meant for use only under medical supervision.

Q: Where are Bosentan 62.5mg Tablets approved and available?

A: Bosentan 62.5mg Tablets are approved for use in Canada, the EU, UK, USA, and Australia, and they are widely available both in India and global export markets.

Q: What are the benefits of using Bosentan 62.5mg Tablets over other treatments?

A: Bosentan provides uncommon and remarkable relief specifically by targeting endothelin receptors, making it highly effective for managing PAH as compared to standard therapies. Its established efficacy and global approvals add to its benefits.

Tell us about your requirement